Nothing Special   »   [go: up one dir, main page]

CL2022001481A1 - Composiciones de ácidos nucleicos - Google Patents

Composiciones de ácidos nucleicos

Info

Publication number
CL2022001481A1
CL2022001481A1 CL2022001481A CL2022001481A CL2022001481A1 CL 2022001481 A1 CL2022001481 A1 CL 2022001481A1 CL 2022001481 A CL2022001481 A CL 2022001481A CL 2022001481 A CL2022001481 A CL 2022001481A CL 2022001481 A1 CL2022001481 A1 CL 2022001481A1
Authority
CL
Chile
Prior art keywords
nucleic acid
acid compositions
aspects
effective
cost
Prior art date
Application number
CL2022001481A
Other languages
English (en)
Inventor
Robbins Abshire James
Dhamankar Himanshu
Farmer William
Gregg Christopher
Original Assignee
Greenlight Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greenlight Biosciences Inc filed Critical Greenlight Biosciences Inc
Publication of CL2022001481A1 publication Critical patent/CL2022001481A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/50—Biochemical production, i.e. in a transformed host cell
    • C12N2330/51—Specially adapted vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/34—Vector systems having a special element relevant for transcription being a transcription initiation element
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/36—Vector systems having a special element relevant for transcription being a transcription termination element

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención proporciona, en algunos aspectos, composiciones de ácidos nucleicos que comprenden una secuencia transcrita inicial y diseños de ácidos nucleicos únicos para la producción rentable y de alto rendimiento de ácidos ribonucleicos
CL2022001481A 2019-12-06 2022-06-03 Composiciones de ácidos nucleicos CL2022001481A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962944824P 2019-12-06 2019-12-06

Publications (1)

Publication Number Publication Date
CL2022001481A1 true CL2022001481A1 (es) 2023-03-17

Family

ID=74046190

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2022001481A CL2022001481A1 (es) 2019-12-06 2022-06-03 Composiciones de ácidos nucleicos

Country Status (10)

Country Link
US (1) US20220411792A1 (es)
EP (1) EP4069843A1 (es)
JP (1) JP2023505188A (es)
KR (1) KR20220113437A (es)
CN (1) CN115397982A (es)
AU (1) AU2020395244A1 (es)
CA (1) CA3163345A1 (es)
CL (1) CL2022001481A1 (es)
MX (1) MX2022006748A (es)
WO (1) WO2021113774A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4304353A4 (en) 2021-03-08 2025-02-12 Greenlight Biosciences Inc RNA-BASED CONTROL OF VINE POWDERY MILDEW
US20220370599A1 (en) * 2021-04-30 2022-11-24 Greenlight Biosciences, Inc. Messenger rna therapeutics and compositions
AU2022282559A1 (en) * 2021-05-26 2024-01-04 Etherna Immunotherapies Nv Method to reduce double stranded rna by-product formation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007503205A (ja) * 2003-08-22 2007-02-22 ニュークレオニクス・インコーポレイテッド 多コンパートメント真核生物発現系
EP3695002A1 (en) 2017-10-11 2020-08-19 GreenLight Biosciences, Inc. Methods and compositions for nucleoside triphosphate and ribonucleic acid production

Also Published As

Publication number Publication date
CN115397982A (zh) 2022-11-25
EP4069843A1 (en) 2022-10-12
KR20220113437A (ko) 2022-08-12
AU2020395244A1 (en) 2022-06-16
US20220411792A1 (en) 2022-12-29
JP2023505188A (ja) 2023-02-08
CA3163345A1 (en) 2021-06-10
WO2021113774A1 (en) 2021-06-10
MX2022006748A (es) 2023-01-19

Similar Documents

Publication Publication Date Title
BR122021025194A8 (pt) Molécula de ácido nucleico, método para obter rna, rna, método para obter um peptídeo ou proteína e usos in vitro ou ex vivo do rna
CL2022001481A1 (es) Composiciones de ácidos nucleicos
MX2020011939A (es) Nuevas enzimas y sistemas crispr.
CO2020015314A2 (es) Composiciones de arni contra el angiotensinógeno (agt) y métodos para su uso
MX2021010075A (es) Variantes de arn polimerasa para la formacion de casquetes cotranscripcionales.
CL2021000028A1 (es) Anticuerpo multiespecifico (divisional de solicitud 937-2020).
CY1124845T1 (el) Μεθοδοι παροχης μονοκλωνου rna
CY1124806T1 (el) Αντισωματα enanti-cd40 και χρησεις αυτων
BR112018076190A2 (pt) ortólogos e sistemas crispr tipo vi
SA518391294B1 (ar) التحرير المتعدد للجينوم
AU2018251801A8 (en) Novel type VI CRISPR orthologs and systems
CR20200192A (es) Métodos y composiciones para la producción de nucleósido trifosfatos y ácidos ribonucleicos
BR112018077188A2 (pt) frutose-6-fosfato-3-epimerase termoestável inovadora e um método para produzir alulose com o uso da mesma
BR112018010805A2 (pt) mutantes de proteína f de rsv
BR112016026950A2 (pt) composições de rnai para angiotensinogênio (agt) e métodos de uso das mesmas
BR112018010341A2 (pt) composição, sistema e método para tratamento do cabelo, método para alteração da cor do cabelo, e, kit de multicompartimentos para alteração da cor ou do formato do cabelo.
CR20140538A (es) Métodos y composiciones para la modificación de adn objetivo dirigida por arn y para la modificación de la transcripción dirigida por arn
CR20190294A (es) COMPOSICIONES DE ARNi DE SERPINA1 Y SUS MÉTODOS DE USO
ES2721309T3 (es) Composición para preparar tagatosa y método para preparar tagatosa a partir de fructosa
CL2021002262A1 (es) Composiciones y métodos para tratar laminopatías
AR100946A1 (es) Composiciones y métodos para regular la expresión génica por medio de la interferencia de arn
WO2020030984A3 (en) Compositions and methods for genome engineering with cas12a proteins
BR112022012731A2 (pt) Anticorpo anti-ox40 e uso do mesmo
BR112016015218A2 (pt) microrganismo com capacidade melhorada de produção de l-treonina e método para produzir l-treonina com o uso desse
WO2016183009A3 (en) Methods and compositions for the specific inhibition of antithrombin 3 (at3) by double-stranded rna